top of page

The New Oral GLP-1: How Foundayo Compares to Wegovy Tablets

Aug 21
3 min read

If you're looking into oral weight loss medication, you've probably come across two names: Wegovy Tablets and Foundayo. Both are once-daily tablets working on the same appetite-regulating hormone system, but they're built differently, taken differently, and backed by separate clinical trials.













Here's how they actually compare.



How Each Tablet Works


Wegovy Tablets contain semaglutide, the same active ingredient as Wegovy injections, in tablet form. Semaglutide is a peptide, a type of molecule that needs careful handling to survive the digestive system intact, which is part of why the tablet requires a specific dosing routine.


Foundayo contains orforglipron, Eli Lilly's oral GLP-1 medicine. Orforglipron is a small molecule rather than a peptide, chemically simpler, and designed from the outset to work as a standard tablet without those extra precautions.


Both work on the same GLP-1 receptor system: slowing gastric emptying, reducing appetite, and increasing the feeling of fullness after eating.


Taking Each Tablet Correctly Matters


Wegovy Tablets

  • Take on an empty stomach, with no more than half a glass of water

  • Take first thing in the morning

  • Wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines

  • Food, drink, or tablets taken too soon can significantly reduce how much of the medicine is absorbed

Foundayo

  • Can be taken with or without food

  • Can be taken with or without water

  • Can be taken at any point in the day

  • No 30-minute waiting period required



What the Trial Evidence Shows


Both medicines have solid trial data behind them, though it's worth being upfront that the figures below come from separate trials in separate patient groups, not a head-to-head study, so they shouldn't be read as one medicine directly beating the other by that exact margin.


  • Wegovy Tablets: 13.6% average weight loss over 64 weeks (OASIS 4 trial)

  • Foundayo: up to 12.4% average weight loss over 72 weeks at the highest dose (ATTAIN-1 trial)


Both results sit well beyond what diet and exercise alone typically achieve. Which one suits you better depends on how your body responds and what fits your daily routine, which is exactly what your consultation with our clinical team is for.





Dose Titration: What to Expect


Both medicines start at a low dose and increase gradually, roughly every 30 days, to reduce the risk of side effects while your body adjusts.


At MSH Weight Loss, we won't increase your medication unless we feel you will benefit from it. If you're achieving good appetite control and weight loss from your current dose, then theres no reason to increase.


Tablet Doses

Wegovy Tablets

Foundayo Tablets

1.5mg

0.8mg

4mg

2.5mg

9mg

5.5mg

25mg

9mg


14.5mg


17.2mg



Common Side Effects During Escalation


Because both medicines work on the same GLP-1 system, their side effect profiles overlap heavily: nausea, constipation, diarrhoea, indigestion and stomach discomfort are common with both, particularly in the first few weeks or after a dose increase, and usually settle down over time.


One difference worth knowing: Foundayo has a somewhat higher reported rate of hair loss in clinical trials 3% vs 7%, particularly in women, compared with placebo. It's not common, but it's reported more frequently with Foundayo than with Wegovy Tablets.


Our clinical team will go through the full side effect profile of whichever medicine you're considering before you start.


The Bottom Line


There's no single right answer here. If the empty-stomach, 30-minute-wait routine feels like a dealbreaker, Foundayo's flexibility may suit you better. If you're already comfortable with Wegovy Tablets and it's working, there's no need to switch just because something new has arrived.


Book a consultation with our clinical team to talk through which option fits you best.


Phone Consultation
15min
Book Now

 
 
bottom of page